会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明专利
    • FATTY ACID AMIDE HYDROLASE INHIBITORS
    • CA2658887A1
    • 2008-01-31
    • CA2658887
    • 2007-07-27
    • UNIV CONNECTICUT
    • MAKRIYANNIS ALEXANDROSNIKAS SPYRIDON PALAPAFUJA SHAKIRU OSHUKLA VIDYANAND G
    • C07D213/02A61K31/4245A61K31/425A61K31/44C07C233/02C07D271/06C07D277/02
    • Disclosed are compounds of formula R-X-Y that may be used to inhibit the action of fatty acid amide hydrolase (FAAH). Inhibition of fatty acid amide hydrolase (FAAH) will slow the normal degradation and inactivation of endoge nous cannabinoid ligands by FAAH hydrolysis and allow higher levels of those endogenous cannabinergic ligands to remain present. These higher levels of endocannabinoid ligands provide increased stimulation of the cannabinoid CBl and CB2 receptors and produce physiological effects related to the activati on of the cannabinoid receptors. They will also enhance the effects of other exogenous cannabinergic ligands and allow them to produce their effects at lower concentrations as compared to systems in which fatty acid amide hydrol ase (FAAH) action is not inhibited. Thus, a compound that inhibits the inact ivation of endogenous cannabinoid ligands by fatty acid amide hydrolase (FAA H) may increase the levels of endocannabinoids and, thus, enhance the activa tion of cannabinoid receptors. Thus, the compound may not directly modulate the cannabinoid receptors but has the effect of indirectly stimulating the c annabinoid receptors by increasing the levels of endocannabinoid ligands. It may also enhance the effects and duration of action of other exogenous cann abinergic ligands that are administered in order to elicit a cannabinergic r esponse.